H-group (homology)
7514.1 Ferredoxin reductase-like, C-terminal NADP-linked domain
Ligands and drugs
1,712
Member domains
442
with ligand contacts (≤ 4 Å)
25.8% of members
398
with DrugDomain annotations
23.2% of members
393
with a DrugBank compound
23.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7514.1 belongs to X-group 7514 Ferredoxin reductase-like, C-terminal NADP-linked domain, which binds 4.8 ligand superclasses per 20 proteins, narrower than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 378 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 98 |
| DB03247 | FMN | Flavin mononucleotide | 38 |
| DB02098 | A2P | Adenosine-2'-5'-Diphosphate | 21 |
| DB18267 | HEM | Ferroheme | 11 |
| DB14128 | NAD | Nadide | 9 |
| DB00157 | NAI | NADH | 6 |
| DB03979 | DGG | 1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol | 5 |
| DB02338 | NDP | NADPH | 4 |
| DB02701 | NCA | Nicotinamide | 3 |
| DB04450 | HTG | Heptyl 1-Thiohexopyranoside | 3 |
| DB00155 | — | Citrulline | 2 |
| DB02027 | — | N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine | 2 |
| DB02044 | — | N-[3-(aminomethyl)benzyl]acetamidine | 2 |
| DB03707 | — | S-Ethyl-N-Phenyl-Isothiourea | 2 |
| DB04223 | — | Nitroarginine | 2 |
| DB08018 | — | N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE | 2 |
| DB08019 | — | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine | 2 |
| DB00115 | — | Cyanocobalamin | 1 |
| DB00134 | — | Methionine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 415 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 99 |
| A2P | ADENOSINE-2'-5'-DIPHOSPHATE | 21 |
| FMN | FLAVIN MONONUCLEOTIDE | 21 |
| MGmetal | MAGNESIUM ION | 18 |
| CL | CHLORIDE ION | 16 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 16 |
| ZNmetal | ZINC ION | 14 |
| NAmetal | SODIUM ION | 13 |
| 2AM | ADENOSINE-2'-MONOPHOSPHATE | 12 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 10 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 10 |
| FDA | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | 8 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 7 |
| CAmetal | CALCIUM ION | 5 |
| U4O | [4-[[(4~{E})-4-(furan-2-ylmethylidene)-2,3-dihydro-1~{H}-acridin-9-yl]carbonyl]piperazin-1-yl]-pyridin-2-yl-methanone | 4 |
| BR | BROMIDE ION | 3 |
| DGG | 1-[GLYCEROLYLPHOSPHONYL]-2-[8-(2-HEXYL-CYCLOPROPYL)-OCTANAL-1-YL]-3-[HEXADECANAL-1-YL]-GLYCEROL | 3 |
| HTG | heptyl 1-thio-beta-D-glucopyranoside | 3 |
| IOD | IODIDE ION | 3 |